4//SEC Filing
Rothbard Jonathan B. 4
Accession 0001213900-21-064722
CIK 0001690080other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:30 PM ET
Size
6.5 KB
Accession
0001213900-21-064722
Insider Transaction Report
Form 4
Rothbard Jonathan B.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-08+300,000→ 300,000 totalExercise: $3.95Exp: 2031-12-08→ Common Stock (300,000 underlying)
Holdings
- 560,449
Common Stock
Footnotes (2)
- [F1]The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
- [F2]The options vest at the rate of 1/3rd of such options at the date of grant with the remaining options vesting at the rate of 24 equal monthly installments, beginning on the last day of December 31, 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001833968
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:30 PM ET
- Size
- 6.5 KB